Cβ
|
53.7/3.12
|
Cβ-Hβ in β-β (resinol) substructures (C)
|
Dβ
|
56.1/3.09
|
Cβ-Hβ in β-1 (spirodienone) substructures (D)
|
-OCH3
|
57.3/3.77
|
C-H in methoxyls
|
Aγ
|
60.0/3.38 to 3.71
|
Cγ-Hγ in β-O-4 substructures (A)
|
A’γ
|
63.8/3.83 to 4.30
|
Cγ-Hγ in γ-acylated β-O-4′ substructures (A’ and A”)
|
Cγ
|
71.7/3.81 and 4.17
|
Cγ-Hγ in β-β (resinol) substructures (C)
|
Aα/A’α
|
72.3/4.86
|
Cα-Hα in β-O-4 substructures (A, A’, and A”)
|
Dα
|
82.1/5.12
|
Cα-Hα in β-1 (spirodienone) substructures (D)
|
A’β
|
83.6/4.32
|
Cβ-Hβ in γ-acylated β-O-4 substructures (A’ and A”)
|
Cα
|
85.4/4.64
|
Cα-Hα in β-β (resinol) substructures (C)
|
Dα’
|
85.4/4.80
|
Cα’-Hα’ in β-1 (spirodienone) substructures (D)
|
Aβ
|
86.5/4.10
|
Cβ-Hβ in γ-OH β-O-4 substructures (A)
|
Bα
|
87.7/5.45
|
Cα-Hα in β-5 (phenylcoumaran) substructures (B)
|
S2,6
|
103.8/6.68
|
C2-H2 and C6-H6 in etherified syringyl units
|
S2,6 (Cα = O)
|
106.7/7.36 and 7.21
|
C2-H2 and C6-H6 in oxidized (Cα = O) syringyl units
|
G2
|
111.5/6.99
|
C2-H2 in guaiacyl units
|
D2’
|
111.6/6.23
|
C2’- H2’ in β-1 (spirodienone) substructures (D)
|
A”β’
|
114.3/6.24
|
Cβ’-Hβ’ in p-coumaroylated substructures (A”)
|
G5
|
115.2/6.71 and 6.94
|
C5-H5 in guaiacyl units
|
A”3’,5’
|
116.2/6.77
|
C3’- H3’ and C5’- H5’ in p-coumaroylated substructures (A”)
|
D6’
|
118.3/6.19
|
C6’- H6’ in β-1 (spirodienone) substructures (D)
|
G6
|
119.5/6.83
|
C6-H6 in guaiacyl units
|
H2,6
|
128.2/7.17
|
C2-H2 and C6-H6 in p-hydroxyphenyl units
|
A”2’,6’
|
130.5/7.4
|
C2’- H2’ and C6’- H6’ in p-coumaroylated substructures (A”)
|
A”α’
|
145.1/7.39 |
Cα’-Hα’ in p-coumaroylated substructures (A”) |